Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Randomized Experiments01:13

Randomized Experiments

9.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.1K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

336
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
336
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

305
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
305
Censoring Survival Data01:09

Censoring Survival Data

609
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
609
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

462
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
462
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

658
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
658

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

MVA-BN monkeypox vaccine safety in a clinical trial in the Democratic Republic of the Congo.

NPJ vaccines·2026
Same author

Assessing Open-world Foundation Models for Zero-shot Skin Segmentation in Clinical Dermatological Photographs.

Proceedings of SPIE--the International Society for Optical Engineering·2026
Same author

Reflections on FDA Draft Guidance on Bayesian Methods in Trials-Protecting Scientific Integrity and Evidentiary Standards.

JAMA·2026
Same author

Event-driven planning of two-armed trials with a binary endpoint.

Clinical trials (London, England)·2026
Same author

Clinical testing of drug treatment shortening in patients with TB using PET/CT imaging of lung lesions.

Science translational medicine·2026
Same author

Maternal and neonatal outcomes after infection with monkeypox virus clade I during pregnancy in DR Congo: a pooled, prospective cohort study.

Lancet (London, England)·2025
Same journal

A statistical evaluation of decision-making methods and the efficiency of Bayesian multi-arm multi-stage trials.

Clinical trials (London, England)·2026
Same journal

Accounting for non-adherence: A re-analysis of the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results trial.

Clinical trials (London, England)·2026
Same journal

Phase I design for partially ordered groups with late-onset toxicity.

Clinical trials (London, England)·2026
Same journal

Trial informed consent forms, the Declaration of Helsinki and the SPIRIT 2025 statement.

Clinical trials (London, England)·2026
Same journal

17th Annual University of Pennsylvania Conference on statistical issues in clinical trials - Covariate adjustment in randomized clinical trials: New methods and applications (Morning panel discussion).

Clinical trials (London, England)·2026
Same journal

17th Annual University of Pennsylvania Conference on statistical issues in clinical trials - Covariate adjustment in randomized clinical trials: New methods and applications (Afternoon panel discussion).

Clinical trials (London, England)·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Feb 26, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Randomización adaptativa a la respuesta con puntos intermedios de resultado imperfectos

Yousra Kherabi1,2,3, Michael A Proschan4, Lori E Dodd3,4

  • 1Infectious and Tropical Diseases Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Clinical trials (London, England)
|February 25, 2026
PubMed
Resumen
Este resumen es generado por máquina.

La aleatorización adaptativa a la respuesta que utiliza puntos intermedios de resultado imperfectos, como la conversión de cultivos en ensayos de tuberculosis, puede no asignar de manera fiable a los pacientes al mejor tratamiento. La precisión del punto final es crucial para la asignación eficaz de pacientes.

Palabras clave:
Tuberculosisdiseños adaptativosensayo clínicopunto final intermedioaleatorización adaptativa a la respuesta

Más Videos Relacionados

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

1.6K

Videos de Experimentos Relacionados

Last Updated: Feb 26, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

1.6K

Área de la Ciencia:

  • Metodología de Ensayos Clínicos
  • Bioestadística
  • Investigación de Enfermedades Infecciosas

Sus antecedentes:

  • La aleatorización adaptativa a la respuesta es objeto de debate, especialmente con resultados primarios a largo plazo.
  • Los puntos finales intermedios se utilizan para actualizar la aleatorización en ensayos que requieren un seguimiento prolongado.
  • Los ensayos de tuberculosis sirven como contexto para evaluar diseños adaptativos con datos imperfectos.

Objetivo del estudio:

  • Evaluar el impacto de la aleatorización adaptativa a la respuesta utilizando un punto final intermedio imperfecto.
  • Evaluar la eficacia de los diseños adaptativos para asignar participantes a brazos de tratamiento superiores.
  • Examinar la influencia de la precisión del punto final intermedio y las tendencias temporales en los resultados del ensayo.

Principales métodos:

  • Se simuló un diseño de aleatorización adaptativa a la respuesta para un ensayo de superioridad de tres brazos.
  • Se utilizó la conversión de cultivos a las 8 semanas como punto final intermedio para un resultado primario de 73 semanas (éxito del tratamiento).
  • Se variaron la sensibilidad, la especificidad y la eficacia real del tratamiento para analizar el rendimiento de la aleatorización adaptativa y el error de tipo I.

Principales resultados:

  • Incluso con una precisión perfecta del punto final intermedio, la aleatorización adaptativa no favoreció consistentemente al brazo que ofrecía mejores resultados.
  • Una menor precisión del punto final intermedio redujo significativamente el objetivo de asignar más pacientes al brazo superior.
  • Las tendencias temporales aumentaron el error de tipo I; la estratificación corrigió esto pero redujo la potencia estadística.

Conclusiones:

  • La aleatorización adaptativa a la respuesta es atractiva para evaluar múltiples regímenes de manera eficiente.
  • Sin embargo, requiere puntos finales intermedios muy precisos, que no garantizan una asignación fiable de los pacientes.
  • La fiabilidad de la aleatorización adaptativa a la respuesta es cuestionable con puntos finales intermedios imperfectos.